Cerebrospinal Fluid Anti-Amyloid-Beta; Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation

Journal of Alzheimer's Disease

Volumn 50, Issue 1, 2016, Pages 1-7

  Carmona Iragui, Maria ^a,b   Fernández Arcos, Ana ^a   Alcolea, Daniel ^a,b   Piazza, Fabrizio ^c,d   Morenas Rodriguez, Estrella ^a,b   Antón Aguirre, Sofia ^a,b   Sala, Isabel ^a,b   Clarimon, Jordi ^a,b   Dols Icardo, Oriol ^a,b   Camacho, Valle ^a   Sampedro, Frederic ^a   Munuera, Josep ^e   Nuñez Marin, Fidel ^a   Lleó, Alberto ^a,b   Fortea, Juan ^a,b   Gómez Ansón, Beatriz ^a,f   Blesa, Rafael ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d Alzheimer's Disease Biomarkers International Network (ICAB)   (Italy)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Biomarkers; cerebral amyloid angiopathy; cerebrospinal fluid; Florbetapir PET; inflammation

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; CORTICOSTEROID; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ANILINE DERIVATIVE; APOLIPOPROTEIN E; AUTOANTIBODY; ETHYLENE GLYCOL DERIVATIVE; FLORBETAPIR; PEPTIDE FRAGMENT;

ADULT; AGED; APHASIA; ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRONCHOPNEUMONIA; CASE REPORT; CEREBELLUM HEMORRHAGE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; DEATH; DEMENTIA; DISEASE MARKER; DYSLIPIDEMIA; ELECTROENCEPHALOGRAM; ENCEPHALITIS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; SIDEROSIS; STEREOTYPY; SYMPTOMATOLOGY; TREATMENT DURATION; VASCULAR AMYLOIDOSIS; VISUAL HALLUCINATION; WHITE MATTER LESION; CEREBROSPINAL FLUID; COMPLICATION; DIAGNOSTIC IMAGING; GENETICS; IMMUNOLOGY; MENINGOENCEPHALITIS; NONPARAMETRIC TEST;

AGED; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; APOLIPOPROTEINS E; AUTOANTIBODIES; CEREBRAL AMYLOID ANGIOPATHY; ETHYLENE GLYCOLS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGOENCEPHALITIS; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY; STATISTICS, NONPARAMETRIC; TAU PROTEINS;

EID: 84954088325     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150614     Document Type: Article

References (18)

1. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55, 250-256.
2. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, FroschMP, Greenberg SM(2007) Course of cerebral amyloid angiopathy-related inflammation. Neurology 68, 1411-1416.
3. Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA (2011) Cerebral amyloid angiopathy related inflammation: Three case reports and a review. J Neurol Neurosurg Psychiatry 82, 20-26.
4. Kimura A, Sakurai T, Yoshikura N, Hayashi Y, Takemura M, Takahashi H, Inuzuka T (2013) Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation. J Neuroinflammation 10, 39.
5. Boncoraglio GB, Piazza F, Savoiardo M, Farina L (2015) Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloidrelated imaging abnormalities and high cerebrospinal fluid anti-A autoantibodies. J Alzheimers Dis 45, 363-367.
6. Sengoku R, Matsushima S, MurakamiY, Fukuda T, Tokumaru AM, Hashimoto M, Suzuki M, Ishiwata K, Ishii K, Mochio S (2014) 11C-PiB PET imaging of encephalopathy associated with cerebral amyloid angiopathy. Intern Med 53, 1997-2000.
7. DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, Galimberti G, Conti E, Curtò NA, Marzorati L, Remida P, Tagliavini F, Savoiardo M, Ferrarese C (2011) Anti-A autoantibodies in the CSF of a patient with CAA-related inflammation: A case report. Neurology 76, 842-844.
8. Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, Nitrini R, Sakaguchi H, Brioschi M, Billo G, Colombo A, Lanzani F, Piscosquito G, Carriero MR, Giaccone G, Tagliavini F, Ferrarese C, Difrancesco JC (2013) Anti-amyloid autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloidmodifying therapies. Ann Neurol 73, 449-458.
9. Alcolea D, Carmona-Iragui M, Suarez-Calvet M, Sánchez-Saudinos M-B, Sala I, Antón-Aguirre S, Blesa R, Clarimón J, Fortea J, Lleó A (2014) Relationship between-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 42, 157-167.
10. Renard D, Castelnovo G, Wacongne A, Le Floch A, Thouvenot E, Mas J, Gabelle A, Labauge P, Lehmann S (2012) Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol 259, 2429-2433.
11. Viswanathan A, Greenberg SM, Anand Viswanathan SMG (2011) Cerebral amyloid angiopathy in the elderly. Ann Neurol 70, 871-880.
12. Verbeek MM, Kremer BPH, Rikkert MO, Van Domburg PHMF, Skehan ME, Greenberg SM (2009) Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol 66, 245-249.
13. DiFrancesco JC, Touat M, Caulo M, Gallucci M, Garcin B, Levy R, Uncini A, Piazza F (2015) Recurrence of cerebral amyloid angiopathy-related inflammation: A report of two cases from the iCA International Network. J Alzheimers Dis 46, 1071-1077.
14. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M (2012) Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: A retrospective analysis. Lancet Neurol 11, 241-249.
15. Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli (2012) Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol 69, 198-207.
16. DiFrancesco JC, Longoni M, Piazza F (2015) Anti-A autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy. Front Neurol 6, 207.
17. LleóA, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Peña-Casanova J, Rojo A, Oliva R (2002) Frequency of mutations in the presenilin and amyloid precursor protein genes in earlyonset Alzheimer disease in Spain. Arch Neurol 59, 1759-1763.
18. Martucci M, Sarria S, Toledo M, Coscojuela P,Vert C, Siurana S, Auger C, Rovira A (2014) Cerebral amyloid angiopathyrelated inflammation: Imaging findings and clinical outcome. Neuroradiology 56, 283-289.